Novartis CEO Vas Narasimhan is confident hybrid work is the future as it enables collaboration with new talent pools, significantly benefiting women and parents, news site BioSpace reported.
In July 2020, the Swiss pharmaceutical company launched a program that required only that employees inform managers about their choice of how and where they would work on a given day, without the need for managerial approval, BioSpace said.
Novartis already has invested in setting their employees up to work from home. Going forward, the company plans to “adjust [its] overall footprint and then invest where appropriate,” Narasimhan was cited as saying.
While Novartis may be planning for a hybrid model, more than 70 percent of business executives foresee an in-office return before 2021 ends. Of these, 60.8 percent don’t have an expectation to change the workstyle previously used before the pandemic, a study by WB Wood found.